G protein-coupled receptor 40 activation ameliorates dextran sulfate sodium-induced colitis in mice via the upregulation of glucagon-likepeptide-2
Authors:
Open Access
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 140 (2) , 144-152
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (19K07109)
- Astellas Pharma (AS2034178)
This publication has 38 references indexed in Scilit:
- Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndromeGut, 2011
- Mechanism of Action of Glucagon-Like Peptide-2 to Increase IGF-I mRNA in Intestinal Subepithelial FibroblastsEndocrinology, 2010
- Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2American Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM TrialGastroenterology, 2007
- Therapeutic Action of Ghrelin in a Mouse Model of ColitisGastroenterology, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty AcidsJournal of Biological Chemistry, 2003
- Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40Nature, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouseGut, 2000